These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 24531750)

  • 1. T lymphocytes restrain spontaneous metastases in permanent dormancy.
    Romero I; Garrido C; Algarra I; Collado A; Garrido F; Garcia-Lora AM
    Cancer Res; 2014 Apr; 74(7):1958-68. PubMed ID: 24531750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastases in immune-mediated dormancy: a new opportunity for targeting cancer.
    Romero I; Garrido F; Garcia-Lora AM
    Cancer Res; 2014 Dec; 74(23):6750-7. PubMed ID: 25411345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. H-2 antigens and tumour-associated transplantation antigens in clones derived from a methylcholanthrene-induced BALB/c tumour: their influence on the generation in vitro and in vivo of the specific anti-tumour immune response.
    Pérez M; Garrido A; Algarra I; Caballero A; Delgado C; Collado MD; Fernández-Cruz E; Garrido F
    Exp Clin Immunogenet; 1989; 6(3):204-18. PubMed ID: 2631798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory role of T lymphocytes and NK cells in tumor allograft development.
    Sobotková E; Nouza K
    Neoplasma; 1993; 40(2):75-80. PubMed ID: 8350958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of MHC class-I transfection on local tumor growth and metastasis in an H-2-negative clone derived from a chemically induced fibrosarcoma.
    Mialdea MJ; Martin J; Gaforio JJ; Algarra I; Pérez M; Gonzalez A; Ljunggren HG; Garrido F
    Int J Cancer; 1992 Aug; 52(1):153-8. PubMed ID: 1500219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chimeric T cell receptor N29gamma redirect T lymphocytes response specific to p185HER2 in A murine model of metastatic breast cancer].
    Li SP; Urban FA; Macgregor JN; Hughes DP; McDonagh KT
    Ai Zheng; 2004 Nov; 23(11 Suppl):1370-5. PubMed ID: 15566639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoselection by T lymphocytes generates repeated MHC class I-deficient metastatic tumor variants.
    Garcia-Lora A; Algarra I; Gaforio JJ; Ruiz-Cabello F; Garrido F
    Int J Cancer; 2001 Jan; 91(1):109-19. PubMed ID: 11149409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A weakly tumorigenic phenotype with high MHC class-I expression is associated with high metastatic potential after surgical removal of the primary murine fibrosarcoma.
    Pérez M; Algarra I; Ljunggren HG; Caballero A; Mialdea MJ; Gaforio JJ; Klein G; Kärre K; Garrido F
    Int J Cancer; 1990 Aug; 46(2):258-61. PubMed ID: 2116997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A syngeneic metastatic tumor model in mice: the natural immune response of the host and its manipulation.
    Treves AJ; Cohen IR; Feldman M
    Isr J Med Sci; 1976; 12(4-5):369-84. PubMed ID: 1084880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of asialo GM 1 positive cells in the control of metastatic spread of tumor cells in mice].
    Shibuya M; Saijo N; Ozaki A; Beppu Y; Shimizu E; Takizawa T; Hoshi A
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1781-6. PubMed ID: 6882003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrosarcoma cells expressing allogeneic MHC Class II antigens induce protective antitumor immunity.
    Leach DR; Callahan GN
    J Immunol; 1995 Jan; 154(2):738-43. PubMed ID: 7814880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MHC Intratumoral Heterogeneity May Predict Cancer Progression and Response to Immunotherapy.
    Romero I; Garrido C; Algarra I; Chamorro V; Collado A; Garrido F; Garcia-Lora AM
    Front Immunol; 2018; 9():102. PubMed ID: 29434605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rejection of tumors in mice with severe combined immunodeficiency syndrome determined by the major histocompatibility complex. Class I expression on the graft.
    Glas R; Waldenström M; Höglund P; Klein G; Kärre K; Ljunggren HG
    Cancer Res; 1995 May; 55(9):1911-6. PubMed ID: 7728758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced metastatic potential of tumor cells harvested from spontaneous metastases of heterogeneous murine tumors.
    Talmadge JE; Fidler IJ
    J Natl Cancer Inst; 1982 Oct; 69(4):975-80. PubMed ID: 6750200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray.
    Li Y; Tang Y; Ye L; Liu B; Liu K; Chen J; Xue Q
    J Cancer Res Clin Oncol; 2003 Jan; 129(1):43-51. PubMed ID: 12618900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor cell dormancy: implications for the biology and treatment of breast cancer.
    Fehm T; Mueller V; Marches R; Klein G; Gueckel B; Neubauer H; Solomayer E; Becker S
    APMIS; 2008; 116(7-8):742-53. PubMed ID: 18834416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antitumor concomitant immunity: a possible metastasis control mechanism].
    Ruggiero RA; Bustuoadad OD; Bonfil RD; Sordelli DO; Fontan P; Meiss RP; Pasqualini CD
    Medicina (B Aires); 1989; 49(3):277-81. PubMed ID: 2487422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of established spontaneous mammary carcinoma metastases following immunotherapy with major histocompatibility complex class II and B7.1 cell-based tumor vaccines.
    Pulaski BA; Ostrand-Rosenberg S
    Cancer Res; 1998 Apr; 58(7):1486-93. PubMed ID: 9537252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy eradicates metastases with reversible defects in MHC class I expression.
    Garrido C; Romero I; Berruguilla E; Cancela B; Algarra I; Collado A; García-Lora A; Garrido F
    Cancer Immunol Immunother; 2011 Sep; 60(9):1257-68. PubMed ID: 21553283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional role of platelets in experimental metastasis studied with cloned murine fibrosarcoma cell variants.
    Mahalingam M; Ugen KE; Kao KJ; Klein PA
    Cancer Res; 1988 Mar; 48(6):1460-4. PubMed ID: 3345518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.